Comparative efficacy of various treatment regimens for androgenetic alopecia in men
- PMID: 12227482
- DOI: 10.1111/j.1346-8138.2002.tb00314.x
Comparative efficacy of various treatment regimens for androgenetic alopecia in men
Abstract
Our understanding of the aetiology of androgenetic alopecia (AGA) has substantially increased in recent years. As a result, several treatment modalities have been tried with promising results especially in early stages of AGA. However, as far as has been ascertained, there is no comprehensive study comparing the efficacy of these agents alone and in combination with each other. One hundered male patients with AGA of Hamilton grades II to IV were enrolled in an open, randomized, parallel-group study, designed to evaluate and compare the efficacy of oral finasteride (1 mg per day), topical 2% minoxidil solution and topical 2% ketoconazole shampoo alone and in combination. They were randomized into four groups. Group I (30 patients) was administered oral finasteride, Group II (36 patients) was given a combination of finasteride and topical minoxidil, Group III (24 patients) applied minoxidil alone and Group IV (10 patients) was administered finasteride with topical ketoconazole. Treatment efficacy was assessed on the basis of patient and physician assessment scores and global photographic review during the study period of one year. At the end of one year, hair growth was observed in all the groups with best results recorded with a combination of finasteride and minoxidil (Group II) followed by groups IV, I and III. Subjects receiving finasteride alone or in combination with minoxidil or ketoconazole showed statistically significant improvement (p<0.05) over minoxidil only recipients. No signifcant side-effects related to the drugs were observed. In conclusion, it is inferred that the therapeutic efficacy is enhanced by combining the two drugs acting on different aetiological aspects of AGA.
Similar articles
-
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.Dermatology. 2004;209(2):117-25. doi: 10.1159/000079595. Dermatology. 2004. PMID: 15316165 Clinical Trial.
-
Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.J Med Assoc Thai. 2012 Oct;95(10):1312-6. J Med Assoc Thai. 2012. PMID: 23193746 Clinical Trial.
-
Controversies in the treatment of androgenetic alopecia: The history of finasteride.Dermatol Ther. 2019 Mar;32(2):e12647. doi: 10.1111/dth.12647. Epub 2018 Sep 25. Dermatol Ther. 2019. PMID: 30253001
-
Androgenetic alopecia: an evidence-based treatment update.Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5. Am J Clin Dermatol. 2014. PMID: 24848508 Review.
-
Multi-therapies in androgenetic alopecia: review and clinical experiences.Dermatol Ther. 2016 Nov;29(6):424-432. doi: 10.1111/dth.12390. Epub 2016 Jul 18. Dermatol Ther. 2016. PMID: 27424565 Review.
Cited by
-
Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia: A Pilot, Randomized Open-Label Study.Int J Trichology. 2023 Mar-Apr;15(2):56-62. doi: 10.4103/ijt.ijt_72_22. Epub 2023 Jul 28. Int J Trichology. 2023. PMID: 37701551 Free PMC article.
-
Androgenetic Alopecia: Therapy Update.Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11. Drugs. 2023. PMID: 37166619 Free PMC article. Review.
-
Overview and Algorithmic Approach to Management of Male and Female Pattern Hair Loss.Indian J Plast Surg. 2021 Dec 14;54(4):416-421. doi: 10.1055/s-0041-1739256. eCollection 2021 Oct. Indian J Plast Surg. 2021. PMID: 34984079 Free PMC article. Review.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. J Cosmet Dermatol. 2021. PMID: 34741573 Free PMC article. Review.
-
Minoxidil-Coated Lysozyme-Shelled Microbubbes Combined With Ultrasound for the Enhancement of Hair Follicle Growth: Efficacy In Vitro and In Vivo.Front Pharmacol. 2021 Apr 27;12:668754. doi: 10.3389/fphar.2021.668754. eCollection 2021. Front Pharmacol. 2021. PMID: 33986689 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous